课题基金 / 基金详情

A new molecular multimodal imaging strategy in brain tumor surgery: Nanoparticle-dependent raman spectroscopy and multispectral optoacoustic tomography for enhancing resection of malignant gliomas.

A new molecular multimodal imaging strategy in brain tumor surgery: Nanoparticle-dependent raman spectroscopy and multispectral optoacoustic tomography for enhancing resection of malignant gliomas.
脑肿瘤手术中的新分子多模态成像策略:纳米颗粒依赖性拉曼光谱和多光谱光声断层扫描,用于增强恶性胶质瘤的切除。
批准号:
259088719
负责人:
Privatdozent Dr. Volker Neuschmelting
金额:
$0.0万
依托单位国家:
德国
项目类别:
Research Fellowships
财政年份:
2014
资助国家:
德国
项目状态:
已结题
起止时间:
2013-12-31 至 2015-12-31

项目摘要

项目成果

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
In glioma surgery a wide variety of techniques have been explored to date, in an effort to better visualize the tumor tissue extent and its margins for removal. Current imaging methods are often limited by inadequate sensitivity, specificity and spatial resolution. A new and unique dual-modality Multisprectral Optoacoustic Tomography (MSOT) and Raman nanoparticle can accurately help delineate the margins of gliomas intraoperatively. Raman spectroscopy is a well-established bioanalytical tool with several key advantages, including excellent sensitivity to small structural and chemical changes, microscopic resolution, multiplexing capabilities, and resistance to both autofluorescence and photobleaching. However, the weakness of this naturally occurring, unenhanced Raman effect tends to limit its utility in the in vivo setting. We intend to overcome this limitation by implementing surface enhanced Raman scattering (SERS) nanoparticles, which increase the Raman signal dramatically. The other disadvantages of Raman are its limited tissue depths penetration and the lack of providing intraoperative images in real-time. We aim to overcome these limitations by the integration of optoacoustic imaging capabilities to the nanoparticle through red-shifting its optical absorbance properties to the near-infrared (NIR). MSOT in the NIR window is an emerging molecular imaging technology in biomedicine that allows to depict intrinsic biomarkers or extrinsic contrast agents with the accuracy of spectroscopy and the depth resolution of ultrasound. This is supposed to be examined in a mouse glioma model in vivo: The MSOT-Raman particles can be detected in both, in vitro and in living mice with at least a femtomolar sensitivity by Raman and a picomolar sensitivity by MSOT. Intravenous injection of MSOT-Raman nanoparticles into glioblastoma-bearing mice leads to accumulation and retention within the tumors, but no accumulation in the surrounding healthy tissue. This allows for noninvasive tumor delineation through the intact skull. The determination of the accumulation of MSOT-Raman nanoparticles in different brain (tumor) cell types, the biodistribution, the toxicity as well as its accuracy in depicting the extent of tumor growth are subject to examination. Raman and optoacoustic imaging may allow the guidance of intraoperative tumor resection by more accurately delineating the brain tumor extent and its margins. Our new dual-modality-nanoparticle approach holds promise for enabling more accurate brain tumor imaging and resection using these novel imaging techniques.
期刊论文(3)
专著(0)
科研奖励(0)
会议论文
DOI: 10.1002/smll.201800740
发表时间: 2018-06
期刊: Small (Weinheim an der Bergstrasse, Germany)
影响因子: --
作者: [Neuschmelting V, Harmsen S, Beziere N, Lockau H, Hsu HT, Huang R, Razansky D, Ntziachristos V, Kircher MF]
通讯作者: Kircher MF
国内基金
海外基金
配子生成素GGN不同位点突变损伤分子伴侣BIP及HSP90B1功能导致精子形成障碍的发病机理
  • 批准号:
    82371616
  • 项目类别:
    面上项目
  • 资助金额:
    49.00万元
  • 批准年份:
    2023
  • 负责人:
    姚晨成
  • 依托单位:
MYRF/SLC7A11调控施万细胞铁死亡在三叉神经痛脱髓鞘病变中的作用和分子机制研究
  • 批准号:
    82370981
  • 项目类别:
    面上项目
  • 资助金额:
    48.00万元
  • 批准年份:
    2023
  • 负责人:
    陈敏洁
  • 依托单位:
PET/MR多模态分子影像在阿尔茨海默病炎症机制中的研究
  • 批准号:
    82372073
  • 项目类别:
    面上项目
  • 资助金额:
    48.00万元
  • 批准年份:
    2023
  • 负责人:
    张淼
  • 依托单位:
GREB1突变介导雌激素受体信号通路导致深部浸润型子宫内膜异位症的分子遗传机制研究
  • 批准号:
    82371652
  • 项目类别:
    面上项目
  • 资助金额:
    45.00万元
  • 批准年份:
    2023
  • 负责人:
    刘开江
  • 依托单位: